HCWB Financial Statements

Balance sheet, income statement, cash flow, and dividends for Hcw Biologics Inc (HCWB).


$16.87M Market Cap.

As of 03/28/2025 5:00 PM ET (MRY) • Disclaimer

HCWB Market Cap. (MRY)


HCWB Shares Outstanding (MRY)


HCWB Assets (MRY)


Total Assets

$30.24M

Total Liabilities

$37.01M

Total Investments

$1.60M

HCWB Income (MRY)


Revenue

$959.40K

Net Income

-$30.02M

Operating Expense

$30.44M

HCWB Cash Flow (MRY)


CF Operations

-$14.23M

CF Investing

-$261.62K

CF Financing

$15.57M

HCWB Dividends (MRY)


Period

Dividends

Yield %

Growth %

Payout Ratio

Coverage Ratio

2024

$0

0%

0%

0%

-

2023

$0

0%

0%

0%

-

2022

$0

0%

0%

0%

-

2021

$0

0%

0%

0%

-

2020

$0

-

-

0%

-

HCWB Balance Sheet (MRY)


Metric

2024

2023

2022

2021

Total Assets

$30,236,578 (6.04%)

$28,513,660 (-39.09%)

$46,809,155 (-12.53%)

$53,514,829 (247.54%)

Assets Current

$5,698,482 (-11.02%)

$6,404,187 (-81.20%)

$34,070,919 (-15.83%)

$40,480,371 (233.21%)

Assets Non-Current

$24,538,096 (10.98%)

$22,109,473 (73.57%)

$12,738,236 (-2.27%)

$13,034,458 (301.13%)

Goodwill & Intangible Assets

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Shareholders Equity

-$6,770,172 (-150.29%)

$13,461,717 (-64.03%)

$37,428,506 (-26.89%)

$51,193,240 (406.21%)

Property Plant & Equipment Net

$22,909,869 (12.01%)

$20,453,184 (89.30%)

$10,804,610 (865.48%)

$1,119,090 (-30.72%)

Cash & Equivalents

$4,674,572 (30.03%)

$3,595,101 (-83.90%)

$22,326,356 (90.32%)

$11,730,677 (38.73%)

Accumulated Other Comprehensive Income

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Deferred Revenue

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Total Investments

$1,599,751 (0.00%)

$1,599,751 (-85.89%)

$11,335,681 (-68.95%)

$36,505,570 (2181.95%)

Investments Current

$0 (0%)

$0 (0%)

$9,735,930 (-61.03%)

$24,983,520 (0%)

Investments Non-Current

$1,599,751 (0.00%)

$1,599,751 (0.00%)

$1,599,751 (-86.12%)

$11,522,050 (620.24%)

Inventory

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Trade & Non-Trade Receivables

$582,201 (-62.09%)

$1,535,757 (267.67%)

$417,695 (214.06%)

$133,000 (-94.68%)

Trade & Non-Trade Payables

$22,332,261 (262.11%)

$6,167,223 (402.97%)

$1,226,156 (448.21%)

$223,664 (43.98%)

Accumulated Retained Earnings (Deficit)

-$100,556,137 (-42.57%)

-$70,532,323 (-54.89%)

-$45,538,046 (-48.64%)

-$30,637,343 (-83.25%)

Tax Assets

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Tax Liabilities

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Total Debt

$13,692,549 (117.19%)

$6,304,318 (-1.65%)

$6,409,893 (0%)

$0 (0%)

Debt Current

$6,314,684 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Debt Non-Current

$7,377,865 (17.03%)

$6,304,318 (-1.65%)

$6,409,893 (0%)

$0 (0%)

Total Liabilities

$37,006,750 (145.86%)

$15,051,943 (60.46%)

$9,380,649 (304.06%)

$2,321,589 (-92.77%)

Liabilities Current

$29,628,885 (238.71%)

$8,747,625 (195.88%)

$2,956,481 (27.35%)

$2,321,589 (131.91%)

Liabilities Non-Current

$7,377,865 (17.03%)

$6,304,318 (-1.87%)

$6,424,168 (0%)

$0 (0%)

HCWB Income Statement (MRY)


Metric

2024

2023

2022

2021

Revenues

$959,403 (71.21%)

$560,360 (-78.33%)

$2,586,378 (0%)

$0 (0%)

Cost of Revenue

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Selling General & Administrative Expense

$22,750,076 (70.40%)

$13,351,204 (60.34%)

$8,326,791 (60.31%)

$5,194,210 (94.61%)

Research & Development Expense

$6,388,994 (-16.77%)

$7,676,316 (-17.80%)

$9,338,365 (14.25%)

$8,173,624 (12.66%)

Operating Expenses

$30,439,070 (15.84%)

$26,277,520 (48.75%)

$17,665,156 (32.15%)

$13,367,834 (34.70%)

Interest Expense

$631,137 (122.98%)

$283,042 (123.47%)

$126,660 (0%)

$0 (0%)

Income Tax Expense

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Loss Income from Discontinued Operations

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Consolidated Income

-$30,023,814 (-20.12%)

-$24,994,277 (-67.74%)

-$14,900,703 (-15.85%)

-$12,862,468 (-121.68%)

Net Income to Non-Controlling Interests

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income

-$30,023,814 (-20.12%)

-$24,994,277 (-67.74%)

-$14,900,703 (-15.85%)

-$12,862,468 (-121.68%)

Preferred Dividends Income Statement Impact

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income Common Stock

-$30,023,814 (-20.12%)

-$24,994,277 (-67.74%)

-$14,900,703 (-15.85%)

-$12,862,468 (-81.83%)

Weighted Average Shares

$38,793,018 (7.97%)

$35,929,446 (0.30%)

$35,822,249 (90.84%)

$18,770,935 (296.07%)

Weighted Average Shares Diluted

$38,793,018 (7.97%)

$35,929,446 (0.30%)

$35,822,249 (90.84%)

$18,770,935 (296.07%)

Earning Before Interest & Taxes (EBIT)

-$29,392,677 (-18.94%)

-$24,711,235 (-67.26%)

-$14,774,043 (-14.86%)

-$12,862,468 (-121.68%)

Gross Profit

$959,403 (71.21%)

$560,360 (-78.33%)

$2,586,378 (0%)

$0 (0%)

Operating Income

-$29,479,667 (-14.63%)

-$25,717,160 (-70.55%)

-$15,078,778 (-12.80%)

-$13,367,834 (-129.51%)

HCWB Cash Flow Statement (MRY)


Metric

2024

2023

2022

2021

Net Cash Flow from Investing

-$261,617 (-106.89%)

$3,797,400 (-74.18%)

$14,708,392 (142.00%)

-$35,018,915 (-18658.59%)

Net Cash Flow from Financing

$15,568,516 (107217.90%)

-$14,534 (-100.23%)

$6,273,397 (-87.27%)

$49,269,475 (320.46%)

Net Cash Flow from Operations

-$14,227,428 (36.81%)

-$22,514,121 (-116.77%)

-$10,386,110 (5.37%)

-$10,975,717 (-5.22%)

Net Cash Flow / Change in Cash & Cash Equivalents

$1,079,471 (105.76%)

-$18,731,255 (-276.78%)

$10,595,679 (223.55%)

$3,274,843 (197.71%)

Net Cash Flow - Business Acquisitions and Disposals

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Cash Flow - Investment Acquisitions and Disposals

$0 (0%)

$10,000,000 (-59.97%)

$24,983,520 (171.44%)

-$34,971,652 (0%)

Capital Expenditure

-$261,617 (95.78%)

-$6,202,600 (39.63%)

-$10,275,128 (-21640.32%)

-$47,263 (74.68%)

Issuance (Repayment) of Debt Securities

$6,785,602 (17829.48%)

-$38,273 (-100.59%)

$6,448,166 (0%)

$0 (0%)

Issuance (Purchase) of Equity Shares

$8,782,914 (36897.83%)

$23,739 (50.46%)

$15,778 (-99.97%)

$56,029,528 (565969.19%)

Payment of Dividends & Other Cash Distributions

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Effect of Exchange Rate Changes on Cash

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Share Based Compensation

$1,009,011 (0.52%)

$1,003,749 (-10.39%)

$1,120,191 (210.32%)

$360,975 (1550.17%)

Depreciation Amortization & Accretion

$1,184,389 (4.33%)

$1,135,184 (57.68%)

$719,943 (25.90%)

$571,854 (-0.18%)

HCWB Financial Metrics (MRY)


Metric

2024

2023

2022

2021

Gross Margin

100.00% (0.00%)

100.00% (0.00%)

100.00%

-

Profit Margin

-3129.40% (29.84%)

-4460.40% (-674.24%)

-576.10%

-

EBITDA Margin

-2940.20% (30.12%)

-4207.30% (-674.25%)

-543.40%

-

Return on Average Equity (ROAE)

839.90% (927.49%)

-101.50% (-198.53%)

-34.00% (59.09%)

-83.10% (-255.04%)

Return on Average Assets (ROAA)

-105.30% (-55.08%)

-67.90% (-124.09%)

-30.30% (20.05%)

-37.90% (31.83%)

Return on Sales (ROS)

-3063.60% (30.53%)

-4409.90% (-672.04%)

-571.20%

-

Return on Invested Capital (ROIC)

-228.40% (-150.99%)

-91.00% (-83.84%)

-49.50% (16.39%)

-59.20% (61.31%)

Dividend Yield

0% (0%)

0% (0%)

0% (0%)

0%

Price to Earnings Ratio (P/E)

-0.58 (66.91%)

-1.75 (61.61%)

-4.56 (-35.60%)

-3.36

Price to Sales Ratio (P/S)

18.04 (-77.03%)

78.55 (196.16%)

26.52

-

Price to Book Ratio (P/B)

-2.49 (-176.11%)

3.27 (78.42%)

1.83 (13.34%)

1.62

Debt to Equity Ratio (D/E)

-5.47 (-588.91%)

1.12 (345.42%)

0.25 (457.78%)

0.04 (102.34%)

Earnings Per Share (EPS)

-0.77 (-10.00%)

-0.7 (-66.67%)

-0.42 (39.13%)

-0.69 (53.69%)

Sales Per Share (SPS)

0.03 (56.25%)

0.02 (-77.78%)

0.07 (0%)

0 (0%)

Free Cash Flow Per Share (FCFPS)

-0.37 (53.32%)

-0.8 (-38.47%)

-0.58 (1.70%)

-0.59 (73.79%)

Book Value Per Share (BVPS)

-0.17 (-146.67%)

0.38 (-64.11%)

1.04 (-61.68%)

2.73 (177.30%)

Tangible Assets Book Value Per Share (TABVPS)

0.78 (-1.89%)

0.79 (-39.25%)

1.31 (-54.16%)

2.85 (-12.25%)

Enterprise Value Over EBIT (EV/EBIT)

-1 (50.00%)

-2 (33.33%)

-3 (40.00%)

-5

Enterprise Value Over EBITDA (EV/EBITDA)

-1.02 (38.81%)

-1.66 (52.24%)

-3.48 (36.88%)

-5.51

Asset Turnover

0.03 (126.67%)

0.01 (-71.70%)

0.05 (0%)

0 (0%)

Current Ratio

0.19 (-73.77%)

0.73 (-93.65%)

11.52 (-33.91%)

17.44 (43.67%)

Dividends

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Free Cash Flow (FCF)

-$14,489,045 (49.54%)

-$28,716,721 (-38.99%)

-$20,661,238 (-87.44%)

-$11,022,980 (-3.81%)

Enterprise Value (EV)

$28,678,075 (-26.81%)

$39,180,791 (-19.89%)

$48,910,597 (-27.82%)

$67,764,147

Earnings Before Tax (EBT)

-$30,023,814 (-20.12%)

-$24,994,277 (-67.74%)

-$14,900,703 (-15.85%)

-$12,862,468 (-121.68%)

Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)

-$28,208,288 (-19.65%)

-$23,576,051 (-67.75%)

-$14,054,100 (-14.35%)

-$12,290,614 (-135.03%)

Invested Capital

$9,625,670 (-57.17%)

$22,475,252 (-19.55%)

$27,936,211 (-29.21%)

$39,462,563 (564.22%)

Working Capital

-$23,930,403 (-921.17%)

-$2,343,438 (-107.53%)

$31,114,438 (-18.46%)

$38,158,782 (242.31%)

Tangible Asset Value

$30,236,578 (6.04%)

$28,513,660 (-39.09%)

$46,809,155 (-12.53%)

$53,514,829 (247.54%)

Market Capitalization

$16,873,016 (-61.71%)

$44,068,848 (-35.84%)

$68,686,691 (-17.13%)

$82,889,220

Average Equity

-$3,574,741 (-114.51%)

$24,633,305 (-43.87%)

$43,886,954 (183.42%)

$15,484,814 (217.33%)

Average Assets

$28,510,201 (-22.50%)

$36,786,948 (-25.13%)

$49,131,612 (44.63%)

$33,970,540 (166.81%)

Invested Capital Average

$12,867,414 (-52.63%)

$27,163,029 (-9.07%)

$29,871,227 (37.52%)

$21,721,770 (472.74%)

Shares

37,823,394 (5.14%)

35,974,570 (0.29%)

35,871,470 (0.40%)

35,728,112 (4.31%)